Oxford researchers behind a novel performance-enhancing ketone drink get around an email a day from sports teams hoping to buy the product – and another 20-30 unnamed professional teams have already been involved in research trials with the product.
The European Specialist Sports Nutrition Alliance (ESSNA) is lobbying for two different solutions to the EU caffeine claim hold up, one of which could see use of the claims limited to sports supplements only.
Antarctica is the southernmost continent on Earth. But while it may be isolated, it is far from insulated and use of its resources like krill has mirrored global political flares from the fall of the Soviet Union to the rise of Chinese state-backed industry.
Swisse Wellness chief executive Radek Sali will step down on December 31 as Hong Kong-listed Biostime International takes full ownership of the Australian firm.
‘We want to enable countries to look after their own children’
Gone are the days when the supply of humanitarian nutrition products relied on just a handful of western companies. UNICEF is pushing its supply of Ready to Use Therapeutic Food (RUTF) into a more competitive future driven by local suppliers ready to...
Economic impact assessments for malnutrition are helping present a “convincing argument” for nutrition investment, says a top economist from the UN’s Food and Agriculture Organisation (FAO).
The Belgian government has set its own maximum levels for added nutrients in foods and supplements in a draft decree that sees yet more national divergence from the road to pan-EU levels.
A pan-EU sustainable food project sees Israeli astaxanthin supplier Algatechnologies, champion of pea protein Roquette and Dutch nutrition giant DSM among its 50 partners that will invest close to €1.2bn over the next seven years.
Start-up Bio-marine Ingredients Ireland (BII) hopes to become a major new supplier of lipids, protein and calcium powders following an initial €15m investment in its plant.
U2 band members Bono and The Edge have been named as major investors in Nuritas, the much-hyped Irish biotech start-up planning to triple its workforce in 2017.
